SeqOne Accelerates Growth and Expansion into Multi-Omics with Life & Soft Acquisition
Strategic acquisition bolsters SeqOne's multi-omics capabilities and expands service offerings with ISO-certified sequencing platform.
Platform features
Feb 10, 2025
Next-Generation Phenotype-Driven Genomic Analysis with SeqOne
SeqOne's DiagAI HPO automates extraction of HPO terms from clinical notes using AI, streamlining phenotype-driven genomi...
Testimonial
Dec 5, 2024
Transforming Patient Care: SeqOne Empowers CHU de Reims with Advanced Genomic Analysis
Professor Anne-Sophie Lèbre of CHU de Reims uses SeqOne for rare disease and oncology genomics, enabling rapid, precise ...
Science
Dec 5, 2024
Nanopore adaptive sampling accurately detects nucleotide variants and improves the characterization of large-scale rearrangement for the diagnosis of cancer predisposition
Here, 30 well-characterized clinical germline samples were studied with adaptive sampling to enrich the full sequence o...
Platform features
Nov 18, 2024
SeqOne’s DiagAI Score Brings Transparency to Genomic Variant Ranking: Unveiling the AI Decision Process with xAI
DiagAI uses inheritance & quality rules based on real diagnostic data, enabling clinicians to understand AI recommendati...
News
Nov 14, 2024
SeqOne Platform Achieves IVDR Certification, Setting New Quality Standards for Clinical Genomic Analysis
SeqOne Platform gets IVDR Class C medical device certification for NGS analysis in oncology and rare diseases, validatin...
Case study
Oct 14, 2024
Precision Medicine at Scale: AP-HM’s Automated Exome Analysis Success Story
APHM and SeqOne partner to automate exome sequencing with AI, processing up to 2,000 rare disease samples yearly for bet...